Ophthalmology Therapeutics: Does current pipeline innovation hold the potential to affect the future ophthalmology market?

This Frontier Pharma: Ophthalmology Therapeutics assesses first-in-class innovation in the ophthalmology pipeline, highlighting key trends in the distribution of these products.

Pune, India - March 14, 2018 /MarketersMedia/ —

The pipeline is varied in terms of molecular targets and molecule types. Products acting on the immune system and neurotransmitter signaling are the most prevalent, but no single target dominates by any clear margin. There are a total of 194 first-in class pipeline products in development for ophthalmologic indications 38% of the 512 pipeline products for which there is a disclosed molecular target. Encompassing gene therapies, slowing of the visual cycle and antisense therapies, the pipeline appears robust and has huge potential to strengthen treatment options for ophthalmological disorders.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs

Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
• Visualize the composition of the ophthalmological disorders market in terms of dominant molecule types and targets, and understand the current unmet needs and how they can be addressed. This knowledge allows a competitive understanding of gaps in the market.
• Analyze the ophthalmological disorders pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating ophthalmological disorders to overcome the overwhelming level of unmet need.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
• Identify commercial opportunities in the ophthalmological disorders deals landscape by analyzing trends in licensing and co-development deals, and a curated list of ophthalmological disorder therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Get this report at: https://www.themarketreports.com/report/buy-now/935550

In the past the ophthalmological disorders therapy area has suffered from a lack of full understanding of the pathophysiology and underlying mechanisms of the diseases. However, as this knowledge has improved vastly in recent years, potential targets have been identified for treatment. As well as the main disorders previously mentioned, there is also interest in developing treatments for indications such as allergic conjunctivitis and retinitis pigmentosa. The approval of a gene therapy for retinitis pigmentosa is indicative of this progress, and represents the first gene therapy approved for an inherited condition by the FDA.

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935550

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/ophthalmology-therapeutics-does-current-pipeline-innovation-hold-the-potential-to-affect-the-future-ophthalmology-market/314326

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs%20%20

Source: MarketersMedia

Release ID: 314326

Latest News

George scores 33 to help Thunder top Clippers 110-104

Dec 16, 2018

OKLAHOMA CITY — Paul George rendered the Los Angeles Clippers' traps and double-teams useless. Oklahoma City's forward shredded the Clippers for 33 points, seven rebounds and six assists in a 110-104 victory on Saturday night. "I'm fine being trapped," George said. "That's where we're going to need our guys the most — for them to make plays out of it. Honestly, I think that's the easiest way for me to get myself going because I make those plays early. And we burn them, we hurt them on those plays. They can't trap me anymore. They put two on the ball,...

Dunn, Markkanen rally Bulls late to beat Spurs, 98-93

Dec 16, 2018

SAN ANTONIO — Chicago Bulls coach Jim Boylen proudly says he learned a lot from San Antonio coach Gregg Popovich during his two seasons as a Spurs assistant. Boylen even learned how to withstand a crisis and it helped him beat his mentor. Kris Dunn scored 24 points, Lauri Markkanen added 23 and the Bulls rallied from a 21-point deficit in the second half to stun the Spurs 98-93 on Saturday night. "He has helped me grow as a coach and a man," Boylen said. "In a strange way, he's got a lot to do with this, too." A Spurs...

Alvarez stops Fielding in 3rd round for 3rd division title

Dec 16, 2018

NEW YORK — Canelo Alvarez threw a Garden party Saturday night. A short and powerful fiesta. Alvarez landed dozens of body punches, knocking down Rocky Fielding four times and stopping him in the third round to earn his third weight class title, taking the WBA super middleweight belt. Coming off his close decision against Gennady Golovkin three months ago to take the WBA and WBC middleweight titles, Alvarez could hear chants of "Canelo! Canelo!" long before he entered the Madison Square Garden ring for the first time. Throughout a lengthy undercard, it was clear who the sellout crowd of 20,112...

Suns beat Wolves, first 2-game win streak in almost a year

Dec 16, 2018

PHOENIX — Victories are rare for the Phoenix Suns. Winning streaks seem downright historic. Devin Booker returned from a six-game absence to score 28 points and Phoenix beat the Minnesota Timberwolves 107-99 on Saturday night, giving the Suns consecutive wins for the first time in almost a year. Deandre Ayton had 18 points and 12 rebounds for the Suns, including 10 points and five boards in the fourth quarter, when Phoenix pulled away. T.J. Warren added 21 points for Phoenix. After being sidelined with a strained hamstring, Booker returned to make 10 of 16 shots and added seven rebounds and...

James, Ball have triple-doubles, Lakers beat Hornets 128-100

Dec 16, 2018

CHARLOTTE, N.C. — LeBron James and Lonzo Ball gave the Lakers multiple triple-doubles in a game for just the second time, and Los Angeles routed the Charlotte Hornets 128-100 on Saturday night for its third win in four games. James had 24 points, 12 rebounds and 11 assists, while Ball had 16 points, 10 rebounds and 10 assists. Magic Johnson and Kareem Abdul-Jabbar are the only other Lakers to accomplish that feat in the same game, doing so on Jan. 22, 1982. James continued his dominance over Charlotte, improving to 27-1 in his last 28 games. He was unstoppable throughout...

About Us

The Final Scoreboard has fast, accurate live scores for you. We provide premium online content from in-depth analysis to the scores and statistics across American and European Sports.

Contact us: sales[at]thefinalscoreboard.com

Subscribe Now!